Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Klinikum Der Universitat Munchen AöR
Sponsor

Klinikum Der Universitat Munchen AöR

Germany Marchioninistraße 15, Hadern, 81377 Munich, Germany

About the sponsor

Research activity includes acute myeloid leukemia, mantle cell lymphoma, and other B-cell lymphoma settings, with interest in cellular and immunologic treatment strategies.

  • CAR-T-cell therapy
  • Bispecific antibody combinations
  • Targeted treatment in relapsed and frontline disease

Trial activity also extends to transplant-related approaches and treatment selection in biologically high-risk lymphoma.

About Specializations

Klinikum Der Universitat Munchen AöR runs clinical trials in conditions such as Hepatocellular carcinoma, Mantle cell lymphoma stage II, Mantle cell lymphoma stage III, Mantle cell lymphoma stage IV, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

16 clinical trials

Vestibular disorder

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Levothyroxine Sodium
  • Sponsor:Klinikum Der Universitat Munchen AöR

Mantle cell lymphoma

Recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glofitamab
  • Sponsor:Klinikum Der Universitat Munchen AöR

Transcatheter aortic valve implantation

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Protamine Sulfate
  • Sponsor:Klinikum Der Universitat Munchen AöR

Hepatocellular carcinoma

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Klinikum Der Universitat Munchen AöR

Schizophrenia

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clemastine
  • Sponsor:Klinikum Der Universitat Munchen AöR

Ischaemic stroke

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dornase Alfa
  • Sponsor:Klinikum Der Universitat Munchen AöR

Chronic hepatitis B

Recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mva-Hbvac
  • Sponsor:Klinikum Der Universitat Munchen AöR

Mantle cell lymphoma stage II+2

Recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Klinikum Der Universitat Munchen AöR

Crohn's disease

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Intestifix
  • Sponsor:Klinikum Der Universitat Munchen AöR

Deep vein thrombosis

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Apixaban
  • Sponsor:Klinikum Der Universitat Munchen AöR

Acute myeloid leukaemia

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Klinikum Der Universitat Munchen AöR

Hepatocellular carcinoma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Klinikum Der Universitat Munchen AöR

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.